The xenograft model of doxycycline-inducible AURKA knockdown NSCLC tumor treated with cisplatin or doxycycline alone demonstrated slower growth of tumor mass compared to that of untreated mice (Figure 2E). This evidence concerns the gene AURKA and neoplasm.